[Evaluation of complement component C4 concentration and immunoglobulins IgA, IgG, and IgM in serum of patients with

M Tomaszewski1, E Zukowska-Szczechowska, W Grzeszczak

  • 1Katedra i Klinika Chorób Wewnetrznych i Diabetologii w Zabrzu Slaskiej AM w Katowicach.

Insights

Hypertensive patients show higher serum concentrations of complement component C4 compared to healthy individuals. This elevation in C4 may indicate immunological disturbances linked to essential hypertension.

Area of Science:

  • Immunology
  • Nephrology
  • Clinical Medicine

Background:

  • Essential hypertension is a complex condition with potential links to immune system dysregulation.
  • Understanding immunological markers in hypertension can offer insights into disease mechanisms and progression.

Purpose of the Study:

  • To compare serum concentrations of complement component C4 and immunoglobulins (IgA, IgG, IgM) between hypertensive patients and healthy controls.
  • To investigate the relationship between these immunological markers and clinical data, including hypertension duration.

Main Methods:

  • Serum samples from 81 hypertensive patients and 34 healthy controls were analyzed.
  • Turbidymetry was used to quantify concentrations of C4, IgA, IgG, and IgM.
  • Statistical analysis was performed to compare groups and assess correlations.

Main Results:

  • Hypertensive patients exhibited significantly higher serum C4 concentrations than controls.
  • No significant differences in serum IgA, IgG, or IgM levels were observed between the groups.
  • A positive correlation was found between hypertension duration and serum C4 concentration.

Conclusions:

  • Elevated serum C4 may serve as a potential biomarker for immunological disturbances in essential hypertension.
  • Standard immunoglobulin levels (IgA, IgG, IgM) do not appear to be directly associated with essential hypertension.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...